Survival of Lactobacillus casei strain Shirota in the intestines of healthy Chinese adults

Microbiology and Immunology

Volumn 59, Issue 5, 2015, Pages 268-276

  Wang, Ran ^a   Chen, Shanbin ^a   Jin, Junhua ^b   Ren, Fazheng ^a   Li, Yang ^a   Qiao, Zhenxing ^a   Wang, Yue ^a   Zhao, Liang ^a  

^a CHINA AGRICULTURAL UNIVERSITY   (China)

^b BEIJING UNIVERSITY OF AGRICULTURE   (China)

Author keywords

Chinese adults; Intestinal microbiota; Recovery of Lactobacillus casei strain Shirota; Short chain fatty acids

Indexed keywords

ACETIC ACID; PROBIOTIC AGENT; PROPIONIC ACID; SHORT CHAIN FATTY ACID; PROPIONIC ACID DERIVATIVE;

ADULT; ARTICLE; BACTERIAL STRAIN; BACTERIAL SURVIVAL; BACTERIUM CULTURE; CHINESE; CONTROLLED STUDY; DENATURING GRADIENT GEL ELECTROPHORESIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FECES ANALYSIS; FECES LEVEL; FEMALE; HUMAN; INTESTINE FLORA; LACTOBACILLUS CASEI; MALE; NONHUMAN; NORMAL HUMAN; SPECIES COMPOSITION; YOUNG ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; BACTERIAL COUNT; BIOTA; CHEMISTRY; FECES; INTESTINE; MICROBIAL VIABILITY; MICROBIOLOGY; PHYSIOLOGY;

BACTERIA (MICROORGANISMS); LACTOBACILLUS CASEI;

ACETIC ACID; ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; BIOTA; COLONY COUNT, MICROBIAL; DENATURING GRADIENT GEL ELECTROPHORESIS; FECES; FEMALE; HEALTHY VOLUNTEERS; HUMANS; INTESTINES; LACTOBACILLUS CASEI; MALE; MICROBIAL VIABILITY; PROBIOTICS; PROPIONATES; YOUNG ADULT;

EID: 84929715042     PISSN: 03855600     EISSN: 13480421     Source Type: Journal    
DOI: 10.1111/1348-0421.12249     Document Type: Article

References (51)

1. Chomarat M., Espinouse D. ( 1991) Lactobacillus rhamnosus septicemia in patients with prolonged aplasia receiving ceftazidime-vancomycin. Eur J Clin Microbiol 10: 44.
2. Kailasapathy K., Chin J. ( 2000) Survival and therapeutic potential of probiotic organisms with reference to Lactobacillus acidophilus and Bifidobacterium spp. Immunol Cell Biol 78: 80-8.
3. Gilliland S.E. ( 1990) Health and nutritional benefits from lactic acid bacteria. Fems Microbiol Lett 87: 175-88.
4. Berrada N., Lemeland J.F., Laroche G., Thouvenot P., Piaia M. ( 1991) Bifidobacterium from fermented milks-survival during gastric transit. J Dairy Sci 74: 409-13.
5. Oozeer R., Mater D.D.G., Goupil-Feuillerat N., Corthier G. ( 2004) Initiation of protein synthesis by a labeled derivative of the Lactobacillus casei DN-114 001 strain during transit from the stomach to the cecum in mice harboring human microbiota. Appl Environ Microbiol 70: 6992-7.
6. Oozeer R., Leplingard A., Mater D.D., Mogenet A., Michelin R., Seksek I., Marteau P., Dore J., Bresson J.L., Corthier G. ( 2006) Survival of Lactobacillus casei in the human digestive tract after consumption of fermented milk. Appl Environ Microbiol 72: 5615-7.
7. Salonen A., De Vos W.M. ( 2014) Impact of diet on human intestinal microbiota and health. Annu Eev Food Sci T 5: 239-62.
8. Reddy B.S. ( 1981) Diet and excretion of bile acids. Cancer Res 41: 366-8.
9. Bertazzoni E., Donelli G., Midtvedt T., Nicoli J., Sanz Y. ( 2013) Probiotics and clinical effects: is the number what counts? J Chemother 25: 193-212.
10. Kimura K., Mccartney A.L., Mcconnell M.A., Tannock G.W. ( 1997) Analysis of fecal populations of bifidobacteria and lactobacilli and investigation of the immunological responses of their human hosts to the predominant strains. Appl Environ Microbiol 63: 3394-8.
11. Holzapfel W.H., Haberer P., Snel J., Schillinger U., Huis In't Veld J.H.J. ( 1998) Overview of gut flora and probiotics. Int J Food Microbiol 41: 85-101.
12. Tuohy K.M., Pinart-Gilberga M., Jones M., Hoyles L., Mccartney A.L., Gibson G.R. ( 2007) Survivability of a probiotic Lactobacillus casei in the gastrointestinal tract of healthy human volunteers and its impact on the faecal microflora. J Appl Microbiol 102: 1026-32.
13. Asahara T., Nomoto K., Watanuki M., Yokokura T. ( 2001) Antimicrobial activity of intraurethrally administered probiotic Lactobacillus casei in a murine model of Escherichia coli urinary tract infection. Antimicrob Agents Chemother 45: 1751-60.
14. Kanazawa H., Nagino M., Kamiya S., Komatsu S., Mayumi T., Takagi K., Asahara T., Nomoto K., Tanaka R., Nimura Y. ( 2005) Synbiotics reduce postoperative infectious complications: a randomized controlled trial in biliary cancer patients undergoing hepatectomy. Langenbeck Arch Surg 390: 104-13.
15. Matsuzaki T., Takagi A., Ikemura H., Matsuguchi T., Yokokura T. ( 2004) Antitumor activity and action mechanisms of Lactobacillus casei through the regulation of immune responses. Biofactors 22: 63-6.
16. Nagao F., Nakayama M., Muto T., Okumura K. ( 2000) Effects. of a fennented milk drink containing Lactobacillus casei strain Shirota on the immune system in healthy human subjects. Biosci Biotechnol Biochem 64: 2706-8.
17. Spanhaak S., Havenaar R., Schaafsma G. ( 1998) The effect of consumption of milk fermented by Lactobacillus casei strain Shirota on the intestinal microflora and immune parameters in humans. Eur J Clin Nutr 52: 899-907.
18. Matsumoto K., Takada T., Shimizu K., Moriyama K., Kawakami K., Hirano K., Kajimoto O., Nomoto K. ( 2010) Effects of a probiotic fermented milk beverage containing Lactobacillus casei strain Shirota on defecation frequency, intestinal microbiota, and the intestinal environment of healthy individuals with soft stools. J Biosci Bioeng 110: 547-52.
19. Yuki N., Watanabe K., Mike A., Tagami Y., Tanaka R., Ohwaki M., Morotomi M. ( 1999) Survival of a probiotic, Lactobacillus casei strain Shirota, in the gastrointestinal tract: Selective isolation from faeces and identification using monoclonal antibodies. Int J Food Microbiol 48: 51-7.
20. Tiengrim S., Leelaporn A., Manatsathit S., Thamlikitkul V. ( 2012) Viability of Lactobacillus casei strain Shirota (LcS) from feces of Thai healthy subjects regularly taking milk product containing LcS. J Med Assoc Thai 95 Suppl 2: S42-7.
21. Russo F., Clemente C., Linsalata M., Chiloiro M., Orlando A., Marconi E., Chimienti G., Riezzo G. ( 2011) Effects of a diet with inulin-enriched pasta on gut peptides and gastric emptying rates in healthy young volunteers. Eur J Nutr 50: 271-7.
22. Brun A.C., Stordal K., Johannesdottir G.B., Bentsen B.S., Medhus A.W. ( 2012) The effect of protein composition in liquid meals on gastric emptying rate in children with cerebral palsy. Clin Nutr 31: 108-12.
23. Odonnell L.J.D., Virjee J., Heaton K.W. ( 1990) Detection of pseudodiarrhea by simple clinical assessment of intestinal transit rate. Brit Med J 300: 439-40.
24. Via L.E., Falkinham J.O. ( 1995) Comparison of methods for isolation of mycobacterium-avium complex DNA for use in PCR and PAPD fingerprinting. J Microbiol Meth 21: 151-61.
25. Muyzer G., Dewaal E.C., Uitterlinden A.G. ( 1993) Profiling of complex microbial populations by denaturing gradient gel electrophoresis analysis of polymerase chain reaction-amplified genes coding for 16S rRNA. Appl Environ Microbiol 59: 695-700.
26. Gafan G.P., Lucas V.S., Roberts G.J., Petrie A., Wilson M., Spratt D.A. ( 2005) Statistical analyses of complex denaturing gradient gel electrophoresis profiles. J Clin Microbiol 43: 3971-8.
27. Goossens D., Jonkers D., Russel M., Stobberingh E., Van Den Bogaard A., Stockbrugger R. ( 2003) The effect of Lactobacillus plantarum 299v on the bacterial composition and metabolic activity in faeces of healthy volunteers: a placebo-controlled study on the onset and duration of effects. Aliment Pharm Therap 18: 495-505.
28. Fujimoto J., Matsuki T., Sasamoto M., Tomii Y., Watanabe K. ( 2008) Identification and quantification of Lactobacillus casei strain Shirota in human feces with strain-specific primers derived from randomly amplified polymorphic DNA. Int J Food Microbiol 126: 210-5.
29. Koebnick C., Wagner I., Leitzmann P., Stern U., Zunft H.J.F. ( 2003) Probiotic beverage containing Lactobacillus casei Shirota improves gastrointestinal symptoms in patients with chronic constipation. Can J Gastroenterol 17: 655-9.
30. Myers R.M., Fischer S.G., Lerman L.S. Maniatis T. ( 1985) Nearly all single base substitutions in DNA fragments joined to a GC-clamp can be detected by denaturing gradient gel electrophoresis. Nucleic Acids Res 13: 3131-45.
31. Sheffield V.C., Cox D.R., Lerman L.S., Myers R.M. ( 1989) Attachment of a 40-base-pair G+ C-rich sequence (GC-clamp) to genomic DNA fragments by the polymerase chain reaction results in improved detection of single-base changes. Pro Nati Acad Sci U S A 86: 232-6.
32. Ercolini D. ( 2004) PCR-DGGE fingerprinting: novel strategies for detection of microbes in food. J Microbiol Methods 56: 297-314.
33. Duncan S.H., Louis P., Flint H.J. ( 2004) Lactate-utilizing bacteria, isolated from human feces, that produce butyrate as a major fermentation product. Appl Environ Microbiol 70: 5810-17.
34. Belenguer A., Duncan S.H., Calder A.G., Holtrop G., Louis P., Lobley G.E., Flint H.J. ( 2006) Two routes of metabolic cross-feeding between Bifidobacterium adolescentis and butyrate-producing anaerobes from the human gut. Appl Environ Microbiol 72: 3593-9.
35. Li M., Li G., Zhu L., Yin Y., Zhao X., Xiang C., Yu G., Wang X. ( 2014) Isolation and characterization of an agaro-oligosaccharide (AO)-hydrolyzing bacterium from the gut microflora of Chinese individuals. Plos ONE 9: e91106.
36. Hu B., Gong Q., Wang Y., Ma Y., Li J., Yu W. ( 2006) Prebiotic effects of neoagaro-oligosaccharides prepared by enzymatic hydrolysis of agarose. Anaerobe 12: 260-6.
37. Kumari R., Ahuja V., Paul J. ( 2013) Fluctuations in butyrate-producing bacteria in ulcerative colitis patients of North India. World J Gastroenterol 19: 3404-14.
38. Meehan C.J., Beiko R.G. ( 2014) A phylogenomic view of ecological specialization in the Lachnospiraceae, a family of digestive tract-associated bacteria. Genome Biol Evol 6: 703-13.
39. Nakamura N., Lin H.C., Mcsweeney C.S., Mackie R.I., Gaskins H.R. ( 2010) Mechanisms of microbial hydrogen disposal in the human colon and implications for health and disease. Annu Rev Food Sci Technol 1: 363-95.
40. Koropatkin N.M., Cameron E.A., Martens E.C. ( 2012) How glycan metabolism shapes the human gut microbiota. Nat Rev Microbiol 10: 323-35.
41. Martinez I., Lattimer J.M., Hubach K.L., Case J.A., Yang J., Weber C.G., Louk J.A., Rose D.J., Kyureghian G., Peterson D.A., Haub M.D., Walter J. ( 2013) Gut microbiome composition is linked to whole grain-induced immunological improvements. Isme J 7: 269-80.
42. Topping D.L., Clifton P.M. ( 2001) Short-chain fatty acids and human colonic function: roles of resistant starch and nonstarch polysaccharides. Physiol Rev 81: 1031-64.
43. Lara-Villoslada F., De Haro O., Camuesco D., Comalada M., Velasco J., Zarzuelo A., Xaus J. Galvez J. ( 2006) Short-chain fructooligosaccharides, in spite of being fermented in the upper part of the large intestine, have anti-inflammatory activity in the TNBS model of colitis. Eur J Nutr 45: 418-25.
44. Wong J.M., De Souza R., Kendall C.W., Emam A., Jenkins D.J. ( 2006) Colonic health: fermentation and short chain fatty acids. J Clin Gastroenterol 40: 235-43.
45. Shioiri T., Yahagi K., Nakayama S., Asahara T., Yuki N., Kawakami K., Yamaoka Y., Sakai Y., Nomoto K., Totani M. ( 2006) The effects of a synbiotic fermented milk beverage containing Lactobacillus casei strain Shirota and transgalactosylated oligosaccharides on defecation frequency, intestinal microflora, organic acid concentrations, and putrefactive metabolites of sub-optimal health state volunteers: a randomized placebo-controlled cross-over study. Biosci Microflora 25: 137-46.
46. Matsumoto K., Takada T., Shimizu K., Kado Y., Kawakami K., Makino I., Yamaoka Y., Hirano K., Nishimura A., Kajimoto O., Nomoto K. ( 2006) The effects of a probiotic milk product containing Lactobacillus casei strain Shirota on the defecation frequency and the intestinal microflora of sub-optimal health state volunteers: a randomized placebo-controlled cross-over study. Biosci Microflora 25: 39-48.
47. Duck L.W., Walter M.R., Novak J., Kelly D., Tomasi M., Cong Y., Elson C.O. ( 2007) Isolation of flagellated bacteria implicated in Crohn's disease. Inflamm Bowel Dis 13: 1191-201.
48. Rampelli S., Candela M., Severgnini M., Biagi E., Turroni S., Roselli M., Carnevali P., Donini L., Brigidi P. ( 2013) A probiotics-containing biscuit modulates the intestinal microbiota in the elderly. J Nutr Health Aging 17: 166-72.
49. Canani R.B., Costanzo M.D., Leone L., Pedata M., Meli R. Calignano A. ( 2011) Potential beneficial effects of butyrate in intestinal and extraintestinal diseases. World J Gastroenterol 17: 1519-28.
50. Hamer H.M., Jonkers D., Venema K., Vanhoutvin S., Troost F.J., Brummer R.J. ( 2007) Review article: the role of butyrate on colonic function. Aliment Pharmacol Ther 27: 104-19.
51. Lodes M.J., Cong Y., Elson C.O., Mohamath R., Landers C.J., Targan S.R., Fort M., Hershberg R.M. ( 2004) Bacterial flagellin is a dominant antigen in Crohn disease. J Clin Invest 113: 1296-306.